Genome Sequencing is a transformative technology that involves determining the complete DNA sequence of an organism. This process unveils the genetic code, providing insights into the order of nucleotide bases comprising an individual's or species' entire genome. Since the completion of the Human Genome Project in 2003, advancements in high-throughput sequencing technologies, such as next-generation sequencing (NGS), have dramatically reduced costs and accelerated the pace of genome sequencing. This has facilitated widespread applications in various fields, including medicine, agriculture, and evolutionary biology. In medicine, genome sequencing is pivotal for understanding the genetic basis of diseases, identifying mutations, and tailoring personalized treatment plans. It plays a crucial role in cancer genomics, rare disease diagnosis, and pharmacogenomics. In agriculture, genome sequencing aids in crop improvement, disease resistance, and breeding programs. Evolutionary studies leverage genome sequencing to unravel the genetic diversity and relationships among species. However, challenges such as data interpretation, privacy concerns, and ethical considerations persist. As technology evolves, advances in long-read sequencing and third-generation sequencing promise further refinement of genome sequencing methodologies, enhancing our understanding of the genetic basis of life and enabling breakthroughs in personalized medicine and scientific discovery.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States